FR2356636B1 - - Google Patents

Info

Publication number
FR2356636B1
FR2356636B1 FR7720092A FR7720092A FR2356636B1 FR 2356636 B1 FR2356636 B1 FR 2356636B1 FR 7720092 A FR7720092 A FR 7720092A FR 7720092 A FR7720092 A FR 7720092A FR 2356636 B1 FR2356636 B1 FR 2356636B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7720092A
Other versions
FR2356636A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2356636A1 publication Critical patent/FR2356636A1/fr
Application granted granted Critical
Publication of FR2356636B1 publication Critical patent/FR2356636B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
FR7720092A 1976-06-30 1977-06-30 Derives d'acides prostanoiques et medicaments qui en contiennent Granted FR2356636A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762629834 DE2629834A1 (de) 1976-06-30 1976-06-30 Neue prostansaeurederivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2356636A1 FR2356636A1 (fr) 1978-01-27
FR2356636B1 true FR2356636B1 (fr) 1980-04-25

Family

ID=5982096

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720092A Granted FR2356636A1 (fr) 1976-06-30 1977-06-30 Derives d'acides prostanoiques et medicaments qui en contiennent

Country Status (11)

Country Link
JP (1) JPS537648A (fr)
BE (1) BE856326A (fr)
CH (2) CH632492A5 (fr)
DE (1) DE2629834A1 (fr)
DK (1) DK292777A (fr)
FR (1) FR2356636A1 (fr)
GB (1) GB1588157A (fr)
IE (1) IE45606B1 (fr)
IT (1) IT1114813B (fr)
LU (1) LU77648A1 (fr)
NL (1) NL7706588A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967236D1 (de) * 1979-07-17 1984-10-31 Pfizer N-alkanesulfonyl 16,16-dimethyl-17-oxaprostaglandin carboxamides
US4292445A (en) * 1980-04-28 1981-09-29 The Upjohn Company Amide and sulfonamide derivatives of 2-decarboxy-2-aminomethyl-PG-type compounds
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
JPS6127087A (ja) * 1984-07-16 1986-02-06 株式会社東芝 誘導加熱調理器
US5385945A (en) * 1992-10-21 1995-01-31 Allergan, Inc. 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1440361A (en) 1972-07-24 1976-06-23 American Cyanamid Co 11-deoxyprostaglandins of the e and f series and the preparation thereof
IE43462B1 (en) * 1975-06-23 1981-03-11 Pfizer Substituted tetranorprostaglandins

Also Published As

Publication number Publication date
CH632493A5 (en) 1982-10-15
FR2356636A1 (fr) 1978-01-27
LU77648A1 (fr) 1977-10-10
DE2629834A1 (de) 1978-01-12
IE45606B1 (en) 1982-10-06
BE856326A (fr) 1977-12-30
JPS537648A (en) 1978-01-24
IE45606L (en) 1977-12-30
CH632492A5 (en) 1982-10-15
DK292777A (da) 1977-12-31
GB1588157A (en) 1981-04-15
NL7706588A (nl) 1978-01-03
IT1114813B (it) 1986-01-27

Similar Documents

Publication Publication Date Title
FR2356636B1 (fr)
DE2657009B2 (fr)
JPS5748812Y2 (fr)
CH597046A5 (fr)
DD125407A1 (fr)
BG23117A1 (fr)
BG23139A1 (fr)
BG23140A1 (fr)
BG23224A1 (fr)
BG23363A1 (fr)
BG23385A1 (fr)
BG23421A1 (fr)
BG23503A1 (fr)
BG26092A1 (fr)
CH592875A5 (fr)
CH593418A5 (fr)
CH593551A5 (fr)
CH594988A5 (fr)
CH595241A5 (fr)
CH595629A5 (fr)
CH595667A5 (fr)
CH597045A5 (fr)
BG23053A1 (fr)
CH597690A5 (fr)
CH597833A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse